S A Pileri

Summary

Affiliation: University of Bologna
Country: Italy

Publications

  1. ncbi Indolent lymphoma: the pathologist's viewpoint
    S A Pileri
    Pathologic Anatomy and Unit of Haematopathology, Institute of Haematology and Clinical Oncology L and A Seràgnoli, Bologna University, Bologna, Italy
    Ann Oncol 15:12-8. 2004
  2. pmc Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics
    S A Pileri
    Pathology and Clinical Units of the Institute of Haematology and Clinical Oncology L and A Seràgnoli, University of Bologna, Italy
    J Clin Pathol 55:684-8. 2002
  3. ncbi Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases
    S A Pileri
    Service of Pathologic Anatomy and Hematopathology, Institute of Haematology and Clinical Oncology L e A Seràgnoli, Bologna University, Italy
    Histopathology 41:1-29. 2002
  4. pmc Hodgkin's lymphoma: the pathologist's viewpoint
    S A Pileri
    Pathologic Anatomy and Haematopathology, Bologna University, Policlinico S Orsola, Via Massarenti 9, 40138 Bologna, Italy
    J Clin Pathol 55:162-76. 2002
  5. ncbi Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification
    S A Pileri
    Chair of Pathologic Anatomy and Lymphoma Unit, L and A Seràgnoli Institute of Haematology and Clinical Oncology, Bologna University, Via Massarenti 9, 40138 Bologna, Italy
    Histopathology 41:482-509. 2002
  6. pmc Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy
    S A Pileri
    Pathology and Clinical Units, Institute of Hematology and Clinical Oncology L and A Seràgnoli, Bologna University, Bologna, Italy
    Am J Pathol 159:915-24. 2001
  7. ncbi Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach
    Stefano Aldo Pileri
    Pathologic Anatomy, Clinical and Pathology Lymphoma Units, Institute of Haematology and Clinical Oncology L and A Seràgnoli, Bologna University, Italy
    Haematologica 87:ECR40. 2002
  8. ncbi The pathologist's view point. Part II --aggressive lymphomas
    S A Pileri
    Service of Pathologic Anatomy and Hematopathology, Institute of Hematology and Oncology L and A Seragnoli, Bologna University, Policlinico S Orsola, Italy
    Haematologica 85:1308-21. 2000
  9. ncbi The pathologist's view point. Part I--indolent lymphomas
    S A Pileri
    Service of Pathologic Anatomy and Haematopathology, Institute Hematology and Oncology L and A Seràgnoli, Bologna University, Policlinico S Orsola, Italy
    Haematologica 85:1291-307. 2000
  10. pmc Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins
    Stefano A Pileri
    Istituto di Ematologia e Oncologia Medica, L e A Seràgnoli Unità Cliniche e di Anatomia Patologica, Universita di Bologna, Bologna, Italy
    Am J Pathol 162:243-53. 2003

Detail Information

Publications39

  1. ncbi Indolent lymphoma: the pathologist's viewpoint
    S A Pileri
    Pathologic Anatomy and Unit of Haematopathology, Institute of Haematology and Clinical Oncology L and A Seràgnoli, Bologna University, Bologna, Italy
    Ann Oncol 15:12-8. 2004
    ..The recent identification of the IRTA gene family corresponding to IG-like receptors differentially expressed in B-cells might contribute to their better understanding...
  2. pmc Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics
    S A Pileri
    Pathology and Clinical Units of the Institute of Haematology and Clinical Oncology L and A Seràgnoli, University of Bologna, Italy
    J Clin Pathol 55:684-8. 2002
    ..The aim of this study was to characterise a PPFLT arising in a 4 year old boy...
  3. ncbi Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases
    S A Pileri
    Service of Pathologic Anatomy and Hematopathology, Institute of Haematology and Clinical Oncology L e A Seràgnoli, Bologna University, Italy
    Histopathology 41:1-29. 2002
    ..This simplified scheme is practical for everyday diagnostic use and should provide a framework for additional investigation of these unusual neoplasms...
  4. pmc Hodgkin's lymphoma: the pathologist's viewpoint
    S A Pileri
    Pathologic Anatomy and Haematopathology, Bologna University, Policlinico S Orsola, Via Massarenti 9, 40138 Bologna, Italy
    J Clin Pathol 55:162-76. 2002
    ..Treatments adjusted to the pathobiological characteristics of the tumour in at risk patients have been proposed and are on the way to being applied...
  5. ncbi Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification
    S A Pileri
    Chair of Pathologic Anatomy and Lymphoma Unit, L and A Seràgnoli Institute of Haematology and Clinical Oncology, Bologna University, Via Massarenti 9, 40138 Bologna, Italy
    Histopathology 41:482-509. 2002
    ..The more recent acquisitions on the pathobiology of DLBCLs are reviewed in the light of the authors' experience, aiming to contribute to the existing debate on the topic...
  6. pmc Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy
    S A Pileri
    Pathology and Clinical Units, Institute of Hematology and Clinical Oncology L and A Seràgnoli, Bologna University, Bologna, Italy
    Am J Pathol 159:915-24. 2001
    ....
  7. ncbi Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach
    Stefano Aldo Pileri
    Pathologic Anatomy, Clinical and Pathology Lymphoma Units, Institute of Haematology and Clinical Oncology L and A Seràgnoli, Bologna University, Italy
    Haematologica 87:ECR40. 2002
  8. ncbi The pathologist's view point. Part II --aggressive lymphomas
    S A Pileri
    Service of Pathologic Anatomy and Hematopathology, Institute of Hematology and Oncology L and A Seragnoli, Bologna University, Policlinico S Orsola, Italy
    Haematologica 85:1308-21. 2000
    ..The authors focus on the key features of aggressive B- and T-cell lymphomas, aiming to contribute to the cross-talk between pathologists and clinicians...
  9. ncbi The pathologist's view point. Part I--indolent lymphomas
    S A Pileri
    Service of Pathologic Anatomy and Haematopathology, Institute Hematology and Oncology L and A Seràgnoli, Bologna University, Policlinico S Orsola, Italy
    Haematologica 85:1291-307. 2000
    ..The authors focus on the key features of B-cell lymphomas with an indolent behavior, aiming to contribute to the cross-talk between pathologists and clinicians...
  10. pmc Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins
    Stefano A Pileri
    Istituto di Ematologia e Oncologia Medica, L e A Seràgnoli Unità Cliniche e di Anatomia Patologica, Universita di Bologna, Bologna, Italy
    Am J Pathol 162:243-53. 2003
    ..However, it differs from other aggressive B-cell lymphomas in that it shows defective immunoglobulin production despite the expression of OCT-2, BOB.1, and PU.1 transcription factors and the lack of IgV(H) gene crippling mutations...
  11. ncbi Acute leukaemia immunophenotyping in bone-marrow routine sections
    S A Pileri
    Service of Pathologic Anatomy and Haematopathology, Institute of Haematology and Clinical Oncology L and A Seràgnoli, Bologna University, Bologna, Italy
    Br J Haematol 105:394-401. 1999
    ....
  12. ncbi Immunohistochemistry of bone-marrow biopsy
    S A Pileri
    Second Service of Pathologic Anatomy Unit of Haematopathology, Bologna University, S Orsola Hospital, Italy
    Leuk Lymphoma 26:69-75. 1997
    ..Herein, the authors focus on the technical procedures, which allow extensive application of immunohistochemistry to the study of BMNB, as well as on the panels of antibodies needed for the identification of the most relevant conditions...
  13. ncbi Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas
    P L Zinzani
    Institute of Hematology and Medical Oncology Seragnoli, University of Bologna, Italy
    Ann Oncol 11:363-5. 2000
    ..The aim of this study was to define the therapeutic efficacy and toxicity of a combination of FLU and mitoxantrone (FN regimen) in untreated LG-NHL...
  14. ncbi Pyothorax-associated lymphoma: description of the first two cases detected in Italy
    S Ascani
    Service of Pathologic Anatomy and Haematopathology, Institute of Haematology and Clinical Oncology L and A Seràgnoli, Bologna University School of Medicine, Italy
    Ann Oncol 8:1133-8. 1997
    ....
  15. ncbi Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients
    S A Pileri
    Institute of Hematology and Clinical Oncology L and A Seràgnoli, University of Bologna, Bologna, Italy
    Leukemia 21:340-50. 2007
    ....
  16. ncbi Partial nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement analysis in diagnostic work-up
    A Gazzola
    Department of Hematology and Oncology L and A Seràgnoli, Hematopathology Unit, S Orsola Malpighi Hospital, Centro Interdipartimentale per la Ricerca sul Cancro G Prodi, University of Bologna, Italy
    Pathologica 103:14-8. 2011
    ..Accordingly, a final diagnosis of NMZL was made. In conclusion, this case is a good example of the crucial role of complete molecular analysis in the diagnostic work up of lymphoproliferative disorders...
  17. pmc Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies
    C Agostinelli
    Department of Haematology and Clinical Oncology L and A Seràgnoli, Bologna University School of Medicine, Bologna, Italy
    J Clin Pathol 61:1160-7. 2008
    ....
  18. ncbi Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary
    A Pileri
    Division of Dermatology, Department of Internal Medicine, Geriatrics and Nephrology, University of Bologna, Bologna, Italy
    G Ital Dermatol Venereol 147:603-8. 2012
    ..BPDCN has an aggressive course, however, it has been suggested that an exclusive cutaneous involvement at presentation is related to a better clinical outcome...
  19. ncbi Clear-cell proliferation of the lung with lymphangioleiomyomatosis-like change
    S A Pileri
    Institute of Haematology and Clinical Oncology L e A Seràgnoli, Bologna University, Bologna, Italy
    Histopathology 44:156-63. 2004
    ..To describe two cases of a peculiar pulmonary lesion, which expand both the morphological and the immunophenotypic spectrum of perivascular epithelioid cell (PEC)-related disorders...
  20. ncbi Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients
    P L Zinzani
    Institute of Hematology and Medical Oncology Seragnoli, University of Bologna, and Institute of Dermatology Immacolata, Rome, Italy
    J Clin Oncol 18:2603-6. 2000
    ..To evaluate the efficacy and toxicity of gemcitabine, a novel pyrimidine antimetabolite with a low-toxicity profile and activity in several solid tumors, in patients with relapsed or refractory cutaneous T-cell lymphomas...
  21. ncbi Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation
    P Tosi
    Institue of Hematology and Medical Oncology, Seragnoli, University of Bologna, Italy
    Haematologica 86:409-13. 2001
    ..The present study was aimed at evaluating thalidomide as single agent therapy for patients who had previously received autologous peripheral blood stem cell transplantation...
  22. ncbi Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study
    P P Piccaluga
    Institute of Hematology and Clinical Oncology L e A Seràgnoli, University of Bologna, Italy
    Leukemia 16:1609-14. 2002
    ..Moreover, MVD significantly decreased in all the responders evaluated after treatment. We conclude that thalidomide is a feasible therapy in MMM patients and looks promising at least to control the growth progression of disease...
  23. ncbi Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma
    T Marafioti
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, UK
    Leukemia 19:856-61. 2005
    ....
  24. ncbi Hodgkin-like lymphoma, simulating anaplastic large cell lymphoma in the patient after renal transplantation--unusual case report and literature review
    B Ziarkiewicz-Wroblewska
    Department of Pathology, Medical University of Warsaw, Warszawa
    Pol J Pathol 59:63-9. 2008
    ..2. Negative reactions with typical immunohistochemical markers for lymphocytes of B cell line do not exclude the possibility of B-cell proliferation...
  25. ncbi Cytokeratin-positive interstitial cell neoplasm: a case report and classification issues
    K Schuerfeld
    Department of Human Pathology and Oncology, Siena University, Siena, Italy
    Histopathology 43:491-4. 2003
    ..We report a case of a CIRC tumour arising in a submandibular lymph node of a 66-year-old male...
  26. ncbi The different expression of key-molecules allows the easy subclassification of Hodgkin's lymphoma cases as well as their distinction from non-Hodgkin's lymphomas
    S A Pileri
    Department of Pathology, Unit of Haematopathology, Institute of Haematology L and A Seragnoli, University of Bologna
    Pathologica 95:227. 2003
  27. pmc How do we define Hodgkin's disease? The authors' reply
    S A Pileri
    J Clin Pathol 56:159. 2003
  28. ncbi Myeloid sarcoma of liver: an unusual cause of jaundice. Report of three cases and review of literature
    P P Piccaluga
    Histopathology 50:802-5. 2007
  29. ncbi Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase
    A Curti
    Leukemia 21:353-5. 2007
  30. ncbi Diffuse large B-cell lymphoma with primary retroperitoneal presentation: clinico-pathologic study of nine cases
    S A Pileri
    , Italy
    Ann Oncol 12:1445-53. 2001
    ....
  31. ncbi Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach
    A L Zignego
    Department of Internal Medicine, Medical School, Center for Research, Transfer and High Education DENOthe, Center for the Study of Systemic Manifestations of Hepatitis Viruses MaSVE, University of Florence, Florence, Italy
    Dig Liver Dis 39:2-17. 2007
    ..Special emphasis will be given to discussion of the most appropriate clinical approaches to be adopted in order to diagnose, treat (possibly prevent) and follow-up extrahepathic diseases in patients with Hepatitis C Virus infection...
  32. ncbi Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas
    S Tedoldi
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
    J Pathol 209:454-63. 2006
    ..Finally, the expression of Jaw1/LRMP in other types of lymphoma and in non-lymphoid tissues/tumours may be of interest in differential diagnosis and research...
  33. ncbi Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties
    B Ziarkiewicz-Wroblewska
    Department of Pathology, Warsaw Medical University, ul Pawińskiego 7, 02 106 Warsaw, Poland
    Transplant Proc 38:168-72. 2006
    ..After additional immunohistochemical studies (BOB and OCT2), we established the final diagnosis of Hodgkin lymphoma-like PTLD. Due to the increasing number of organ transplantations, doctors of various specialties may encounter PTLD...
  34. ncbi Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype
    R Orduz
    Histopathology 47:645-6. 2005
  35. ncbi Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma
    D Rossi
    Leukemia 19:2363-6. 2005
  36. ncbi Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology
    L Leoncini
    Dipartimento di Patologia Umana ed Oncologia, University of Siena, Nuovo Policlinico Le Scotte, Italy
    Histopathology 46:241-55. 2005
    ....
  37. ncbi Challenging paradigms in lymphoma treatment
    M Bendandi
    Department of Hematology and Cell Therapy Area, University Clinic, University of Navarra, Avda Pio XII 36, 31008 Pamplona, Spain
    Ann Oncol 15:703-11. 2004
  38. ncbi CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphoma
    V Franco
    Istituto di Anatomia e Istologia Patologica, University of Palermo, Palermo, Italy
    Histopathology 44:381-6. 2004
    ..It is not clear if the neoplastic clone is composed of virgin or somatically mutated B cells. CD27 is reported to be a hallmark of memory B cells...
  39. ncbi Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial
    Maurizio Martelli
    Department of Cellular Biotechnology and Hematology, University La Sapienza of Rome, Italy
    J Clin Oncol 21:1255-62. 2003
    ..To evaluate the role of early intensification with high-dose therapy (HDT) and autologous stem-cell transplantation (ASCT) as front-line chemotherapy for patients with high-risk, histologically aggressive non-Hodgkin's lymphoma (NHL)...